Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021.

COVID-19 RT-PCR epidemiology simulations statistical modelling variant virus

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
07 2021
Historique:
entrez: 16 7 2021
pubmed: 17 7 2021
medline: 21 7 2021
Statut: ppublish

Résumé

We analysed 9,030 variant-specific RT-PCR tests performed on SARS-CoV-2-positive samples collected in France between 31 May and 21 June 2021. This analysis revealed rapid growth of the Delta variant in three of the 13 metropolitan French regions and estimated a +79% (95% confidence interval: 52-110%) transmission advantage compared with the Alpha variant. The next weeks will prove decisive and the magnitude of the estimated transmission advantages of the Delta variant could represent a major challenge for public health authorities.

Identifiants

pubmed: 34269174
doi: 10.2807/1560-7917.ES.2021.26.28.2100573
pmc: PMC8284044
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Epidemics. 2021 Jun;35:100459
pubmed: 34015676
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Euro Surveill. 2021 Mar;26(9):
pubmed: 33663644
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Euro Surveill. 2021 Jun;26(23):
pubmed: 34114541
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Emerg Infect Dis. 2021 May;27(5):1496-1499
pubmed: 33769253
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Biol Lett. 2011 Apr 23;7(2):210-3
pubmed: 20810425

Auteurs

Samuel Alizon (S)

MIVEGEC, CNRS, IRD, Université de Montpellier, Montpellier, France.

Stéphanie Haim-Boukobza (S)

Laboratoire Cerba, Saint Ouen L'Aumône, France.

Vincent Foulongne (V)

Laboratoire de Virologie, CHU de Montpellier, France.

Laura Verdurme (L)

Laboratoire Cerba, Saint Ouen L'Aumône, France.

Sabine Trombert-Paolantoni (S)

Laboratoire Cerba, Saint Ouen L'Aumône, France.

Emmanuel Lecorche (E)

Laboratoire Cerba, Saint Ouen L'Aumône, France.

Bénédicte Roquebert (B)

Laboratoire Cerba, Saint Ouen L'Aumône, France.

Mircea T Sofonea (MT)

MIVEGEC, CNRS, IRD, Université de Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH